Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,427
Closed -$1.78M 142
2025
Q4
$1.78M Buy
5,427
+232
+4% +$73.6K 0.22% 64
2025
Q3
$1.47M Buy
5,195
+50
+1% +$14.5K 0.17% 68
2025
Q2
$1.44M Buy
5,145
+26
+0.5% +$7.37K 0.18% 67
2025
Q1
$1.59M Buy
+5,119
New +$1.51M 0.2% 55
2024
Q4
Sell
-4,810
Closed -$1.55M 144
2024
Q3
$1.55M Sell
4,810
-213
-4% -$69.7K 0.18% 49
2024
Q2
$1.57M Buy
5,023
+274
+6% +$80.5K 0.22% 39
2024
Q1
$1.35M Buy
4,749
+452
+11% +$132K 0.27% 39
2023
Q4
$1.24M Buy
4,297
+640
+18% +$174K 0.23% 34
2023
Q3
$983K Buy
+3,657
New +$913K 0.06% 43

Other funds holding AMGN

Fiducient Advisors's AMGN Position: Q1 2026 in Review

Fiducient Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 5,427 shares — an estimated $1.78M sold.

Fiducient Advisors first reported a position in AMGN in Q3 2023 and held it in 9 quarters. The position peaked at $1.78M in Q4 2025. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fiducient Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Fiducient Advisors sold 5,427 Amgen shares in Q1 2026, an estimated $1.78M.
  • Fiducient Advisors first reported a position in Amgen in Q3 2023 and held it in 9 quarters.
  • Fiducient Advisors's Amgen position peaked at $1.78M in Q4 2025.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fiducient Advisors's 13F filing for Q1 2026, filed 11 May 2026.